Unknown

Dataset Information

0

Anti-Inflammatory Effects of Shenfu Injection against Acute Lung Injury through Inhibiting HMGB1-NF-?B Pathway in a Rat Model of Endotoxin Shock.


ABSTRACT: Shenfu injection (SFI), a Chinese herbal medicine with substances extracted from Ginseng Radix et Rhizoma Rubra and Aconiti Lateralis Radix Praeparata, is widely used as an anti-inflammatory reagent to treat endotoxin shock in China. However, the mechanism of SFI in endotoxin shock remains to be illuminated. High mobility group box 1 (HMGB1), a vital inflammatory factor in the late stage of endotoxin shock, may stimulate multiple signalling cascades, including ?B (NF-?B), a nuclear transcription factor, as well as tumour necrosis factor (TNF)-? and interleukin (IL)-1?, among others in the overexpression of downstream proinflammatory cytokines. An investigation into the effects of SFI on the inhibition of the HMGB1-NF-?B pathway revealed the contribution of SFI to acute lung injury (ALI) in a rat model of endotoxin shock. To assess the anti-inflammatory activity of SFI, 5?ml/kg, 10?ml/kg, or 15?ml/kg of SFI was administered to different groups of rats following an injection of LPS, and the mean arterial pressure (MAP) at 5?h and the survival rate at 72?h were measured. 24?h after LPS injection, we observed pathological changes in the lung tissue and measured the mRNA expression, production, translocation, and secretion of HMGB1, as well as the expression of the NF-?B signal pathway-related proteins inhibitor of NF-?B (I?B)-?, P50, and P65. We also evaluated the regulation of SFI on the secretion of inflammatory factors including interleukin-1 beta (IL-1?) and TNF-?. SFI effectively prevented the drop in MAP, relieved lung tissue damage, and increased the survival rate in the endotoxin shock model in dose-dependent manner. SFI inhibited the transcription, expression, translocation, and secretion of HMGB1, increased the expression of toll-like receptor (TLR4), increased the production of I?B-?, and decreased the levels of P65, P50, and TNF-? in the lung tissue of endotoxin shock rats in a dose-dependent manner. Furthermore, SFI decreased the secretion of proinflammatory cytokines TNF-? and IL-1?. In summary, SFI improves the survival rate of endotoxin shock, perhaps through inhibiting the HMGB1-NF-?B pathway and thus preventing cytokine storm.

SUBMITTER: Liu X 

PROVIDER: S-EPMC6875290 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-Inflammatory Effects of Shenfu Injection against Acute Lung Injury through Inhibiting HMGB1-NF-<i>κ</i>B Pathway in a Rat Model of Endotoxin Shock.

Liu Xia X   Ai Fei F   Li Hui H   Xu Qin Q   Mei Liyan L   Miao Jifei J   Wen Quan Q   Zhang Chaoying C   Zhang Saixia S   Zhou Jianhong J   Chen Xiangyun X   Chu Chunwei C   Guo Junfeng J  

Evidence-based complementary and alternative medicine : eCAM 20191103


Shenfu injection (SFI), a Chinese herbal medicine with substances extracted from <i>Ginseng Radix et Rhizoma Rubra</i> and <i>Aconiti Lateralis Radix Praeparata</i>, is widely used as an anti-inflammatory reagent to treat endotoxin shock in China. However, the mechanism of SFI in endotoxin shock remains to be illuminated. High mobility group box 1 (HMGB1), a vital inflammatory factor in the late stage of endotoxin shock, may stimulate multiple signalling cascades, including <i>κ</i>B (NF-<i>κ</i  ...[more]

Similar Datasets

| S-EPMC8817133 | biostudies-literature
| S-EPMC4493574 | biostudies-other
| S-EPMC9592700 | biostudies-literature
| S-EPMC7589024 | biostudies-literature
| S-EPMC9388613 | biostudies-literature
| S-EPMC3309172 | biostudies-literature
| S-EPMC5555014 | biostudies-other
| S-EPMC5856750 | biostudies-literature
| S-EPMC6447716 | biostudies-other
| S-EPMC7339783 | biostudies-literature